RADIENT PHARMACEUTICALS CORP
CIK 0000838879
Revenue (TTM)
—
FY Jun 2012
Net Income (TTM)
−$63.81M
−0.6% YoY
FY Jun 2012
EPS Diluted (TTM)
—
FY Jun 2012
Gross Margin
—
FY Jun 2012
Operating Margin
—
FY Jun 2012
Net Margin
—
FY Jun 2012
Free Cash Flow (TTM)
−$5.68M
FY Jun 2012
Cash
—
FY Jun 2012
Total Debt
—
FY Jun 2012
Shares Outstanding
1.35B sh
FY Jun 2012
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.